Cannabidiol-enriched cannabis extraction product in Parkinson’s disease: A randomized, double-blind, and placebo-controlled trial in Buriram Hospital

OBJECTIVES: The objective of this study was to assess cannabidiol-enriched cannabis extraction product (CBDEP) efficacy in patients with Parkinson’s disease (PD). MATERIALS AND METHODS: Forty patients with PD were randomly assigned to the sublingual CBDEP (n = 20) or placebo (n = 20) group. All pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanjanarangsichai, Auempa, Mitarnun, Witoon, Mitarnun, Wenika, Pangwong, Wilasinee, Laoharattanahirun, Nutchaya, Kajornrith, Warut, Junlaor, Panomporn, Nonghan, Pawarin, Witthayapirote, Wannisa, Sangkarom, Gorawan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Scientific Scholar 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894020/
https://www.ncbi.nlm.nih.gov/pubmed/36743777
http://dx.doi.org/10.25259/JNRP-2022-6-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894020/
https://www.ncbi.nlm.nih.gov/pubmed/36743777
http://dx.doi.org/10.25259/JNRP-2022-6-19

Ejemplares similares